Results 281 to 290 of about 521,807 (336)
Investigating the dynamics and uncertainties in portfolio optimization using the Fourier-Millen transform. [PDF]
Alkhudaydi MH, Alharthi AM.
europepmc +1 more source
Statistical post-editing of a rule-based machine translation system
Antonio L. Lagarda+4 more
openalex +1 more source
From Code to Life: The AI‐Driven Revolution in Genome Editing
This review explores AI‐driven advancements in genome editing, focusing on CRISPR optimization, enhanced targeting precision, reduced off‐target effects, and novel tool design. It addresses ethical challenges, data biases, and highlights future prospects in precision medicine, agriculture, and synthetic biology.
Zhidong Li+10 more
wiley +1 more source
Identification of endoplasmic reticulum stress and mitochondrial dysfunction related biomarkers in osteoporosis. [PDF]
Chen Y+6 more
europepmc +1 more source
BrainFusion is a low‐code software framework for multimodal brain–computer interface (BCI) and brain–body interaction research. It supports electroencephalography (EEG), functional near‐infrared spectroscopy (fNIRS), electromyography (EMG), and electrocardiography (ECG) integration with standardized preprocessing, feature fusion, and model ...
Wenhao Li+10 more
wiley +1 more source
A Multi-Feature Fusion Approach for Road Surface Recognition Leveraging Millimeter-Wave Radar. [PDF]
Qiu Z+6 more
europepmc +1 more source
A Phase‐Separated SR Protein Reprograms Host Pre‐mRNA Splicing to Enhance Disease Susceptibility
This study identifies SR30, a splicing factor, as a negative regulator of tomato immunity. During Phytophthora infestans infection, the elevated SR30 forms nuclear condensates to suppress the alternative splicing (AS) of defense‐related genes in a phase separation manner.
Dong Yan+11 more
wiley +1 more source
Simple tool implementing Bucher's method for indirect treatment comparisons in meta-analyses. [PDF]
Tingle SJ+5 more
europepmc +1 more source
Irisin is a crucial plasma biomarker and promising therapeutic target that reflects disease severity, pulmonary vascular remodeling status and clinical outcome in patients with pulmonary arterial hypertension (PAH). As a novel protective factor, irisin is downregulated in PAH. By ubiquitination, irisin promotes Enolase 1 degradation and suppresses cell
Na Sun+15 more
wiley +1 more source